<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372618">
  <stage>Registered</stage>
  <submitdate>23/03/2017</submitdate>
  <approvaldate>1/05/2017</approvaldate>
  <actrnumber>ACTRN12617000629336</actrnumber>
  <trial_identification>
    <studytitle>Adrenal cortical response during Extracorporeal membrane oxygenation.</studytitle>
    <scientifictitle>Adrenal cortical response during Extracorporeal membrane oxygenation in children and adults admitted to Intensive Care.</scientifictitle>
    <utrn>U1111-1196-0828 </utrn>
    <trialacronym />
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endocrine disorder due to stress from critical illness</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other endocrine disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Serum-cortisol and Cortisol binding globulin will be assessed three times dialy on day 1, 2, 5, 10, 20, 30, etc. in all ages. For adult patients a Synacthen test will be performed day 3. The investigation continues till the patient is discharged from the ICU.</interventions>
    <comparator>Not applicable - observational</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Maintained diurnal Cortisol pattern during critical illness.
</outcome>
      <timepoint>Serum-cortisol will be assessed three times daily day 1,2, 5, 10, 20, 30, etc. until ICU discharge. Samples will be  taken with routine labs at 6 am, and at 4 and 11 pm.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Serum cortisol bindning globulin (CBG) during critical care with ECMO support. </outcome>
      <timepoint>Serum-CBG will be assessed once daily on day 1,2, 5, 10, 20, 30, etc. until ICU discharge. Samples will be  taken with routine labs at 6 am, and at 4 and 11 pm.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality.</outcome>
      <timepoint>Until discharge from ICU.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality.</outcome>
      <timepoint>Until 30 days after admittance to the ICU.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mortality.</outcome>
      <timepoint>Until hospital discharge.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Consecutive patients admitted to the PICU or ECMO ICU at Karolinska University Hospital,  expected to stay at least 48 hours in any of these ICU:s, and not on high-dose cortico steroids.</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>78</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Moribund, or patients not expected to stay in the Intensive care unit for more than 48 hours, or pateints on high-dose cortico steroids.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Comparisons between chategorical data will be performed with Chi2- or Fisher's exact test. Analysis of nominal normal distributed data will be performed with t-test, while non-normal distributed data with Mann Whitney U-test. Normal distribution will be checked with Shapiro-Wilks test. A p-value less than 0.05 will be considered  a significant difference.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/05/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>30/06/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>30/06/2108</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Stockholm</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Karolinska University Hospital</primarysponsorname>
    <primarysponsoraddress>Eugeniavagen 23
17176 STOCKHOLM</primarysponsoraddress>
    <primarysponsorcountry>Sweden</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Karolinska University Hospital</fundingname>
      <fundingaddress>Eugeniavagen 23
17176 STOCKHOLM</fundingaddress>
      <fundingcountry>Sweden</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Karolinska Institutet</sponsorname>
      <sponsoraddress>Dept Physiology and Phamacology
Nanna Swartz vag
Karolinska Institutet
17177 SStockholm</sponsoraddress>
      <sponsorcountry>Sweden</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Karolinska Institutet</sponsorname>
      <sponsoraddress>Dept Endocrinology, Metabolism and Diabetes
Karolinska University Hospital
17176  STOCKHOLM</sponsoraddress>
      <sponsorcountry>Sweden</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a single center prospective observational study on adreno-cortical changes during critical illness in children and adults. The aim is to elucidate if the diurnal changes in serum cortisol is impared during critical illness in all ages, both in ECMO but also in pediatric intensive care patients. Concerining the adult population  we will also perform a Synacthen test on Day 3.
Secondary aims are ICU and survival over the longer run (All cause mortality at 1, 3 and 5 years).
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Regional Ethical Committee in Stockholm</ethicname>
      <ethicaddress>Nobels vag
Karolinska Institutet
17177 Stockholm</ethicaddress>
      <ethicapprovaldate>25/04/2017</ethicapprovaldate>
      <hrec>2017/450-31/1</hrec>
      <ethicsubmitdate>27/02/2017</ethicsubmitdate>
      <ethiccountry>Sweden</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Lars MIKAEL Broman</name>
      <address>ECMO Centre Karolinska
Pediatric Perioperative Medicine and Intensive Care
Karolinska University Hospital
17176 Stockholm</address>
      <phone>+46-70-4909474</phone>
      <fax>+46-8-51778060</fax>
      <email>lars.broman@sll.se</email>
      <country>Sweden</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Lars MIKAEL Broman</name>
      <address>ECMO Centre Karolinska
Pediatric Perioperative Medicine and Intensive Care
Karolinska University Hospital
17176 Stockholm</address>
      <phone>+46-70-4909474</phone>
      <fax>+46-8-51778060</fax>
      <email>lars.broman@sll.se</email>
      <country>Sweden</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Lars MIKAEL Broman</name>
      <address>ECMO Centre Karolinska
Pediatric Perioperative Medicine and Intensive Care
Karolinska University Hospital
17176 Stockholm</address>
      <phone>+46-70-4909474</phone>
      <fax>+46-8-51778060</fax>
      <email>lars.broman@sll.se</email>
      <country>Sweden</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Lars MIKAEL Broman</name>
      <address>ECMO Centre Karolinska
Pediatric Perioperative Medicine and Intensive Care
Karolinska University Hospital
17176 Stockholm</address>
      <phone>+46-70-4909474</phone>
      <fax>+46-8-51778060</fax>
      <email>lars.broman@sll.se</email>
      <country>Sweden</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>